SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
GENSET - GENXY
An SI Board Since April 1998
Posts SubjectMarks Bans Symbol
200 12 0 GENXY
Emcee:  L. Phil Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
100Cres And Genset Complete Major Corn Genomics Milestone biz.yahoo.com martinJongmans-9/7/2000
99nice genxy article today in ftmarketwatch ftmarketwatch.com{437CBA56-F433-469E-dalroi-8/24/2000
98Genset Added to SBF120 and SBF250 Indeces at SBF-Paris-Bourse biz.yahoo.com maJongmans-8/21/2000
97ML initiates coverage Genset with Accumulate, long term buy. Target $ 23.50 marJongmans-8/16/2000
96Genset + 7% today in Paris (Euro 69.90) martinJongmans-8/11/2000
95Robertson Stephens reiterated it its Genset report ( July 5th) Strong Buy.. marJongmans-7/25/2000
94Biotech Experts Debate The Genome Revolution (Inc. Genset's Daniel Cohen) Jongmans-7/24/2000
93Genset Reports Second Quarter 2000 Financial Results biz.yahoo.com martinJongmans-7/19/2000
92SNP consortium snp.cshl.org It seems a little unfair to me that the consortiumMike McFarland-7/19/2000
91Not recent, but interesting: Ceres Inc. (20% owned by Genset) Forms Plant GenetJongmans-7/19/2000
90Mike, Did you see the WSJ Article on Genset/Pernet (Dated 7/4/00)? If not, yoJongmans-7/16/2000
89Mr Pernet will be officially President August 1st.I expect more news and reportJongmans-7/15/2000
88Thanks Stuart--more on genetic markers, you may want to skip down to the paragrMike McFarland-7/14/2000
87Cambridge Healthtech Institute's Second Annual Pharmacogenomics: A New Scripsim1-7/9/2000
86"Buy" Rating Goldman Sachs (E) target: Euro 150 (= ADR $ 48.-) martiJongmans-7/7/2000
85"Buy" Recommendation Close Brothers (+Comment) europeaninvestor.com Jongmans-7/6/2000
84New CEO,Genome Promise Lend Support to Genset FT/Reuters: news.ft.com martinJongmans-7/5/2000
83S.G. Cowen Securities reiterates Buy recommendation MartinJongmans-7/5/2000
82S.G. Cowen Securities reiterates Buy recommendation MartinJongmans-7/5/2000
81(2) Genset Names Andre G. Pernet, Ph.D., President and CEO biz.yahoo.com martiJongmans-7/4/2000
80Genset Appoints Andre Pernet To Succeed Pascal Brandys as Chairman From WSJ IntJongmans-7/4/2000
79Genset overlooked.. www10.nytimes.com martinJongmans-7/3/2000
78 The conversioprice is fixed: 94 Euro.. MartinJongmans-6/28/2000
77 could the strange weakness of today (most genoproteomics are up) eg prm in londdalroi-6/28/2000
76 Even more so today... As a shareholder (& with perfect hindsight) I do wishnigel bates-6/28/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News